Parkinson's disease The second most common Neurodegenerative disease, more affected 10 million people worldwide. It is characterised by changes in movement, including jerking, and slower and more rigid movements. But researchers are also starting to analyze other symptoms of Parkinson's disease — including Including the eye..
Parkinson's results from the degeneration of dopamine neurons within the brain's basal ganglia – an area involved in voluntary movement. Although there isn’t a cure for Parkinson's, symptoms could be managed with drugs that replace dopamine.
There is no single diagnostic test. For Parkinson's there’s a blood-brain barrier (which protects the brain from pathogens circulating within the bloodstream) and the skull makes it difficult to evaluate the brain. As a result Subjective assessment of symptoms Used to diagnose patients.
Given that Parkinson's is thought to affect the body's motor system, it is maybe not surprising that it has been shown. Disruption of eye movements. Promisingly, Parkinson's could be diagnosed with technologies that exist already by showing subtle changes in eye movements and the thinning of specific layers within the retina. This may help measure the effectiveness of treatment and determine disease progression.
Changes in movement
Studies investigating Parkinson's effects on eye movements have focused on the rapid, ballistic movements of our eyes toward a stimulus (called saccades). On the contrary, antisaccadesVoluntary movements of our eyes are triggered away from the stimulus. Early education Errors in antisaccades – whereby participants didn’t look away from a lightweight stimulus – were higher in individuals with Parkinson's.
Another studywhich is used. Deep brain stimulation, found that targeting the globus pallidus interna—the brain region partially answerable for conscious movement—reduced the variety of antisaccade errors. The only surgical procedure for Parkinson's disease is deep brain stimulation. It works by directing electricity to specific areas of the brain. Stimulation targeting an adjoining region, the subthalamic nucleus, had no effect. recently, The researchers found Stimulation of the subthalamic nucleus increases antisaccade errors and delays away from and toward the stimulus.
Although the evidence from a small variety of motivational studies is conflicting, they make clear how Parkinson's disease may occur. Effects on eye movements.
A study from earlier this year Describes 85% of recently diagnosed Parkinson's patients with rhythmic eyelid fluttering when the eyes are closed. These small changes in movement could be measured virtually using webcams. However, larger studies are needed to analyze the potential of eyelid flutter as a diagnostic tool.
Thinning of the retina
Researchers have identified an abnormal accumulation of proteins. Alpha-synuclein Brain regions involved in voluntary movement in patients with Parkinson's disease. Alpha-synuclein is found throughout the brain, although its function just isn’t yet well defined. It is believed to control the synthesis of dopamine, which in turn helps regulate movement.
Interestingly, A A handful of recent studies Accumulation of alpha-synuclein has been present in the retinal tissue of Parkinson's patients in comparison with healthy samples. gave Amount of alpha synuclein The finding also correlates with the severity of the disease – although this potential indicator of disease can only be detected from post-mortem tissue samples.
Optical coherence tomography (OCT) scans, which take cross-sectional images of ten separate layers of the retina, can allow researchers to detect retinal changes in living patients. These scans are fast, non-invasive, relatively inexpensive and simple to make use of.
Oh No OCT studies have to date shown retinal thinning in Parkinson's patients. Not only dopamine neurons are found. Specific areas of the retinathese regions were neighboring retinal layers. Alpha-synuclein was found to harbor. Studies show. Retinal thinning occurs selectively in these layers of the retina, potentially marking the early onset of Parkinson's disease.
Preloff/Shutterstock
Along with diagnosing Parkinson's, eye tests also can help track the progression of the disease. a study 126 participants were included to see if OCT scans and easy visual chart tests were related to dementia risk in patients with Parkinson's disease (an algorithm was used Calculate the risk).
People with Parkinson's disease who were classified as having the best risk of dementia fared worse on vision tests. These patients were also found to have more retinal thinning. These findings weren’t replicated in participants who had the same risk of dementia, but weren’t diagnosed with Parkinson's.
However, one of these study has limitations. The variety of patients involved and other aspects — reminiscent of the medications they take — can affect the outcomes. It can be difficult to perform eye tests on patients with very severe symptoms.
Big data
As more patients are studied, more details about Parkinson's disease could be learned. Large data studies could also be useful due to Parkinson's disease. Relatively common And eye scans have gotten increasingly routine. This allows researchers to research a lot of OCT scans and retinal images previously taken on patients with and without Parkinson's.
There are such databases, which is the most important. Insight Data Hub for Eye Healthwhich comprises Millions of eye scans With anonymized medical histories of over 250,000 patients. A population-based approach, combined with the usage of machine learning (a sort of artificial intelligence) and Deep learning (a subset of machine learning), can uncover patterns by sifting through large databases. Researchers can use multiple eye scans from the identical patient. Help investigate disease progression.
A growing body of evidence suggests that changes in eye movements and retinal structure result from dopamine depletion, which is an indicator of Parkinson's disease. Other Visual disturbances, reminiscent of changes in rapid eye movements during sleep, motion perception, and color vision, are also under investigation. Importantly, these changes could be detected non-invasively.